Pluristem Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Pluristem Therapeutics ( PSTI) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. This stock is trading up 12.3% at $4.00 in recent trading.

Today's Range: $3.75-$4.20

52-Week Range: $1.98-$4.23

Volume: 2.4 million

Three-Month Average Volume: 531,278

>>7 Stocks Soaring on Heavy Volume

From a technical perspective, PSTI is gapping up sharply here right off some near-term support at $3.51 with heavy volume. This move is quickly pushing PSTI within range of triggering a major breakout trade. That trade will trigger once PSTI takes out some key overhead resistance at $4.23 to $4.38 with high volume.

Traders should now look for long-biased trades in PSTI as long as this stock is trending above $3.50, and then once it clears $4.23 to $4.38 with high volume. Look for a sustained move or close above those levels with volume that's near or above 531,278 shares. If that major breakout triggers soon, then PSTI has a chance to head well north of $5 in the near future.

To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under-$10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to and maintains the website, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.

If you liked this article you might like

5 Biotech Stocks Under $10 Set to Soar

Insiders Trading GEVA, GNOM, VPRT, HSON

Complete Genomics Stock Falls On Unusually High Volume (GNOM)

Complete Genomics Stock Hits New 52-Week Low (GNOM)